Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.330
+0.040 (3.10%)
At close: Mar 6, 2026, 4:00 PM EST
1.340
+0.010 (0.75%)
After-hours: Mar 6, 2026, 4:11 PM EST
Pliant Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
171
Market Cap
81.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.58M | -8.11M | -83.69% |
| Dec 31, 2022 | 9.69M | 2.11M | 27.91% |
| Dec 31, 2021 | 7.57M | -34.25M | -81.89% |
| Dec 31, 2020 | 41.82M | -15.24M | -26.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Champions Oncology | 58.42M |
| Verrica Pharmaceuticals | 30.83M |
| Pelthos Therapeutics | 7.41M |
| Coeptis Therapeutics Holdings | 501.00K |
| Seres Therapeutics | 351.00K |
| Fractyl Health | 3.00K |
PLRX News
- 11 days ago - Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference - GlobeNewsWire
- 3 months ago - Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors - Benzinga
- 3 months ago - Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - GlobeNewsWire
- 3 months ago - Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - GlobeNewsWire
- 4 months ago - Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 7 months ago - Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 9 months ago - Pliant Therapeutics Provides Update on BEACON-IPF - GlobeNewsWire
- 10 months ago - Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference - GlobeNewsWire